GlassScriptPhysician profile
Igor Wroblewski
NPI 1265816516
$2,198.33
in general payments reported to CMS, 2019-2025
21 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $16.91 · 2021: $259 · 2022: $249 · 2023: $813 · 2024: $518 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924 · Education: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.91 |
| Education | $543.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $399.06 | 2023-2024 | Onyx Frontier |
| Janssen Pharmaceuticals, INC | $290.86 | 2019-2024 | Xarelto |
| Abbott Laboratories | $290.75 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Mitraclip |
| Abiomed | $198.41 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.13 | 2021-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $160.66 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $124.45 | 2022 | |
| Edwards Lifesciences Corporation | $115.28 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $108.30 | 2022 | |
| Merck Sharp & Dohme LLC | $59.95 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $42.02 | 2024 | Uptravi |
| Shockwave Medical, INC | $40.17 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $32.93 | 2023 | Heartrail, Metacross Otw, Glidesheath Slender |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.53 | 2025 | Jardiance |
| Getinge USA Sales, LLC | $26.53 | 2023 | Cardiosave Hybrid, Type B Plug |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.88 | 2024 | |
| Boston Scientific Corporation | $22.12 | 2021 | |
| Heartflow, INC. | $18.23 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.03 | 2021 | |
| Bridgebio Pharma, INC. | $17.95 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, LTD. | $16.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Wroblewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.